Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care
Prostate Cancer Vaccines: What’s the Latest?
Researchers Uncover Key Actor in Spread of Breast Cancer to the Brain
Expanding Possibilities - Researchers Dive Deep to Identify Exceptional Responders
High-Dose Vitamin D3 Does Not Provide Benefit for Metastatic Colorectal Cancer
Breast Cancer Research: New Studies Show How Post-Treatment Lifestyle Choices Shape Long-Term Outcomes After Diagnosis
Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy
Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer
Comprehensive Cancer Research from Dana-Farber Leads ESMO Congress 2024
Pancreatic Cancer: Study Finds Most Early Staging Inaccurate
Adolescent Glioma Subtype Responds to CDK4/6 Inhibitor
Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation
Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies
Early Action, Better Outcomes: Transforming Cancer Prevention
Showing 166 - 180 of 1032 results
Previous| 1... 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
